ReShape Medical® Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer SAN CLEMENTE, CALIF.—August 8, 2016—ReShape Medical Inc. today announced the appointment of Michael J. Mangano as President and Chief Executive Officer. Mr....
Versartis Announces Completion of Enrollment in Phase 3 VELOCITY Trial of Somavaratan in Pediatric GHD Total of 137 patients enrolled; top-line results expected in Q3 2017 MENLO PARK, Calif., Aug. 22, 2016 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an...
Kit Check Names Cameron Ferroni as Chief Product Officer Washington, DC – Kit Check™ (https://kitcheck.com), the leader in hospital pharmacy kit restocking and medication tracking software, today announced Cameron Ferroni as Chief Product Officer. Ferroni will lead...
Edge Therapeutics Announces Closing of $20 Million Debt Facility with Hercules Capital, Inc. BERKELEY HEIGHTS, N.J., Aug. 02, 2016 (GLOBE NEWSWIRE) — Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based...
Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925 Evanston, Ill., July 13, 2016 – Aptinyx Inc., a biopharmaceutical company developing novel modulators of the N-methyl-D-aspartate (NMDA) receptor for the treatment of...
Recent Comments